Betamethasone Sodium Phosphate
FDA-approved product (injectable, injection), marketed as Betamethasone Sodium Phosphate, Celestone.
- Registered studies
- 50+
- Lab records
- 0
- Pathogens at ≥40%
- 1 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBLApproved for
- Airway obstruction
- Eye inflammation
- Hemorrhoid
- Nasal congestion
- Ulcerative colitis
Indications ChEMBL records as approved, from FDA and DailyMed labels. Label ↗
- WHO therapeutic group
- Corticosteroids acting locally; Corticosteroids; Corticosteroids, potent (group iii); Corticosteroids, potent, other combinations; Glucocorticoids
- Anti-infective classification
- Not classified as an anti-infective.
Repurposing investigation
This medicine is being investigated here for AI-predicted antimicrobial activity against MRSA. It was surfaced computationally for further investigation; it is not an established treatment for this infection.
AI-predicted activity
AI prediction · nothing measured- MRSA56.2% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
- E. coli36.1% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- K. pneumoniae32.3% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- M. tuberculosis31.6% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
50+registered studies name this medicine, for any condition. The registry search keeps the first 50, so there may be more. See them below.
Experimental
No evidence found
No laboratory measurement against the four pathogens in the ChEMBL records loaded here.
Docking
Computational · nothing measuredAutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Betamethasone Sodium Phosphate with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- DactinomycinExisting use: Kidney Wilms tumor, Neoplasm95.6% AI-predicted activityagainst MRSALab records exist50+ registered studies
- TaurursodiolExisting use: Bile acids and derivatives79.6% AI-predicted activityagainst MRSA43 registered studies
- LinaclotideExisting use: Constipation, Constipation disorder, Irritable bowel syndrome74.5% AI-predicted activityagainst MRSA50+ registered studies
- PlecanatideExisting use: Constipation74.4% AI-predicted activityagainst MRSA15 registered studies
- OxytocinExisting use: Hemorrhage, Uterine Inertia74.2% AI-predicted activityagainst MRSA50+ registered studies
- PosaconazoleExisting use: Aspergillosis, Candidiasis, Coccidioidomycosis and 2 more72.2% AI-predicted activityagainst MRSA50+ registered studies
- SotorasibExisting use: Neoplasm, Non-small cell lung carcinoma70.6% AI-predicted activityagainst MRSA50+ registered studies
- TemsirolimusExisting use: Cancer, Clear cell renal carcinoma, Mantle cell lymphoma and 2 more70.1% AI-predicted activityagainst MRSA50+ registered studies
- Quizartinib DihydrochlorideExisting use: Acute myeloid leukemia, Myeloid leukemia70.0% AI-predicted activityagainst MRSA4 registered studies
- Irinotecan HydrochlorideExisting use: Adenocarcinoma, Cancer, Carcinoma and 4 more70.0% AI-predicted activityagainst MRSA50+ registered studies
- Deoxycholic AcidExisting use: Other dermatologicals69.3% AI-predicted activityagainst MRSA50+ registered studies
- ChenodiolExisting use: Cerebrotendinous xanthomatosis, Inborn errors of metabolism69.2% AI-predicted activityagainst MRSA30 registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
Pre-incisional Infiltration With Ropivacaine Plus Diprospan for Relieving Postoperative Pain After Laparoscopic Surgery
NCT07626463 · start 2026-05-30
Registered record
- Registry ID
- NCT07626463
- Conditions
- Laparoscopic Surgery; Laparoscopic Appendectomy; Laparoscopic Cholecystectomy; Laparoscopic Hernia Repair Surgery; Infiltration Anesthesia
- Interventions
- Pre-incisional infiltration with ropivacaine and diprospan; Pre-incisional infiltration with ropivacaine alone
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Recruiting
- Start
- 2026-05-30
- Completion
- 2028-05-30
- Enrolment
- 150
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionLaparoscopic Surgery; Laparoscopic Appendectomy; Laparoscopic Cholecystectomy; Laparoscopic Hernia Repair Surgery +1 moreInterventionPre-incisional infiltration with ropivacaine and diprospan; Pre-incisional infiltration with ropivacaine alonePhaseNot applicableRegistry statusRecruitingPRP vs PRP+Betamethasone vs Betamethasone Injection for Upper Trapezius Myofascial Pain
NCT07547605 · start 2026-05-15
Registered record
- Registry ID
- NCT07547605
- Conditions
- Myofascial Pain Dysfunction Syndrome; Trigger Points, Myofascial; Trigger Point in Trapezius Muscle
- Interventions
- Autologous Platelet-Rich Plasma (PRP); PRP plus Betamethasone; Betamethasone (Diprospan)
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Recruiting
- Start
- 2026-05-15
- Completion
- 2027-01
- Enrolment
- 150
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMyofascial Pain Dysfunction Syndrome; Trigger Points, Myofascial; Trigger Point in Trapezius MuscleInterventionAutologous Platelet-Rich Plasma (PRP); PRP plus Betamethasone; Betamethasone (Diprospan)PhasePhase 4Registry statusRecruitingEfficacy of Corticosteroid Injection and Nerve Hydrodissection in Carpal Tunnel Syndrome
NCT06882603 · start 2025-10-14
Registered record
- Registry ID
- NCT06882603
- Conditions
- Carpal Tunnel Syndrome (CTS)
- Interventions
- hydrodissection; Steroid injection; Exercise
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Recruiting
- Start
- 2025-10-14
- Completion
- 2026-05-05
- Enrolment
- 90
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionCarpal Tunnel Syndrome (CTS)Interventionhydrodissection; Steroid injection; ExercisePhaseNot applicableRegistry statusRecruitingRopiclobet for Regional Anesthesia and Post-Operative Pain Control in Upper Extremity Surgery
NCT07131657 · start 2025-09-02
Registered record
- Registry ID
- NCT07131657
- Conditions
- Nerve Block; Upper Extremity Surgery
- Interventions
- Ropivacaine + Clonidine + Betamethasone; Ropivacaine + Clonidine + Betamethasone; Ropivacaine + Clonidine + Betamethasone
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Completed
- Start
- 2025-09-02
- Completion
- 2025-12-09
- Enrolment
- 40
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionNerve Block; Upper Extremity SurgeryInterventionRopivacaine + Clonidine + Betamethasone; Ropivacaine + Clonidine + Betamethasone; Ropivacaine + Clonidine + BetamethasonePhasePhase 2Registry statusCompletedEffect of Pre-delivery Dexamethasone in Comparison With Betamethasone on Fetal Heart Trace
NCT07078786 · start 2025-07-13
Registered record
- Registry ID
- NCT07078786
- Conditions
- Cardiotocography; Steroids
- Interventions
- Betamethason Sodium Phosphate; Dexamethasone
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Recruiting
- Start
- 2025-07-13
- Completion
- 2025-10-15
- Enrolment
- 110
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionCardiotocography; SteroidsInterventionBetamethason Sodium Phosphate; DexamethasonePhasePhase 4Registry statusRecruitingPeriodontal Initial Treatment Combined With Glucocorticoid Therapy for Erosive Oral Lichen Planus
NCT06498180 · start 2024-12-31
Registered record
- Registry ID
- NCT06498180
- Conditions
- Oral Lichen Planus; Periodontal Diseases
- Interventions
- Periodontal initial treatment under local anesthesia; Glucocorticoid Therapy; oral hygiene instruction
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Not yet recruiting
- Start
- 2024-12-31
- Completion
- 2028-03-31
- Enrolment
- 29
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionOral Lichen Planus; Periodontal DiseasesInterventionPeriodontal initial treatment under local anesthesia; Glucocorticoid Therapy; oral hygiene instructionPhaseNot applicableRegistry statusNot yet recruitingPhase I Study of Ropivacaine, Clonidine, and Betamethasone Combination for Sciatic Nerve Block in the Popliteal Region
NCT06781632 · start 2024-11-13
Registered record
- Registry ID
- NCT06781632
- Conditions
- Healthy; Nerve Block
- Interventions
- ropivacaine
- Study type
- INTERVENTIONAL
- Phase
- Phase 1
- Registry status
- Completed
- Start
- 2024-11-13
- Completion
- 2025-04-25
- Enrolment
- 12
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHealthy; Nerve BlockInterventionropivacainePhasePhase 1Registry statusCompletedAnalgesic Efficacy of Preemptive Stepwise Infiltration Anesthesia for Perioperative Analgesia After TKA
NCT06600815 · start 2024-09-30
Registered record
- Registry ID
- NCT06600815
- Conditions
- Total Knee Arthroplasty; Pain Management
- Interventions
- preemptive stepwise infiltration anaesthesia(PSIA); postoperative local infiltration analgesia(PLIA)
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Recruiting
- Start
- 2024-09-30
- Completion
- 2025-12
- Enrolment
- 110
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionTotal Knee Arthroplasty; Pain ManagementInterventionpreemptive stepwise infiltration anaesthesia(PSIA); postoperative local infiltration analgesia(PLIA)PhaseNot applicableRegistry statusRecruitingEffectiveness of a Single Dose of Betamethasone in Children With Symptomatic Adenovirus Infection
NCT06299813 · start 2024-03-20
Registered record
- Registry ID
- NCT06299813
- Conditions
- Adenovirus
- Interventions
- Bentelan; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Unknown
- Start
- 2024-03-20
- Completion
- 2026-04-01
- Enrolment
- 80
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAdenovirusInterventionBentelan; PlaceboPhasePhase 3Registry statusUnknownThe Effects of Two Different Treatment Protocols on Shoulder Function, Quality of Life, and Ultrasound Parameters in Patients With Frozen Shoulder
NCT05956171 · start 2023-10-01
Registered record
- Registry ID
- NCT05956171
- Conditions
- Frozen Shoulder; Shoulder Capsulitis; Shoulder Pain
- Interventions
- Intra-articular corticosteroid injection; Ultrasound Guided Hydrodilatation with corticosteroid injection
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2023-10-01
- Completion
- 2024-03
- Enrolment
- 50
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionFrozen Shoulder; Shoulder Capsulitis; Shoulder PainInterventionIntra-articular corticosteroid injection; Ultrasound Guided Hydrodilatation with corticosteroid injectionPhaseNot applicableRegistry statusUnknownSingle Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS)
NCT05114096 · start 2023-07-20
Registered record
- Registry ID
- NCT05114096
- Conditions
- Preterm Birth; Premature Birth; Complication of Prematurity; Obstetric Labor, Premature; Pregnancy Complications
- Interventions
- Celestone + placebo; Celestone + Celestone
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Recruiting
- Start
- 2023-07-20
- Completion
- 2029-12-31
- Enrolment
- 3,254
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPreterm Birth; Premature Birth; Complication of Prematurity; Obstetric Labor, Premature +1 moreInterventionCelestone + placebo; Celestone + CelestonePhasePhase 4Registry statusRecruitingCorticosteroids in Carpal Tunnel Syndrome. Prospective Randomised Controlled Non-inferiority Study
NCT06272682 · start 2023-07-17
Registered record
- Registry ID
- NCT06272682
- Conditions
- Carpal Tunnel Syndrome
- Interventions
- Systemic bethametasone injection; Local bethametasone injection
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2023-07-17
- Completion
- 2025-10-11
- Enrolment
- 106
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionCarpal Tunnel SyndromeInterventionSystemic bethametasone injection; Local bethametasone injectionPhaseNot applicableRegistry statusUnknownInvestigation of the Effect of Central Sensitization (CS) on Steroid Injection Response in Rotator Cuff Lesion
NCT05926895 · start 2023-06-02
Registered record
- Registry ID
- NCT05926895
- Conditions
- Central Sensitisation; Subacromial Impingement Syndrome
- Interventions
- Injection of 1 CC Betamethasone Dipropionate + Betamethasone Sodium Phosphate (Diprospan) and 4 cc 2% Prilocaine (Priloc)mixture into the subacromial space
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2023-06-02
- Completion
- 2024-12-30
- Enrolment
- 44
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionCentral Sensitisation; Subacromial Impingement SyndromeInterventionInjection of 1 CC Betamethasone Dipropionate + Betamethasone Sodium Phosphate (Diprospan) and 4 cc 2% Prilocaine (Priloc)mixture into the subacromial spacePhaseNot applicableRegistry statusCompletedSafety & Efffficacy of Genakumab in Patients With Frequent Flares
NCT05983445 · start 2023-01-11
Registered record
- Registry ID
- NCT05983445
- Conditions
- Acute Gout Arthritis
- Interventions
- genakumab; placebo for Diprospan; placebo for genakumab; Diprospan
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Completed
- Start
- 2023-01-11
- Completion
- 2024-04-03
- Enrolment
- 313
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAcute Gout ArthritisInterventiongenakumab; placebo for Diprospan; placebo for genakumab; DiprospanPhasePhase 3Registry statusCompletedOpioid-free Total Hip Arthroplasty
NCT04421196 · start 2022-09-15
Registered record
- Registry ID
- NCT04421196
- Conditions
- Hip Osteoarthritis
- Interventions
- Exclusion of opioid analgesics
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Withdrawn
- Start
- 2022-09-15
- Completion
- 2023-12-01
- Enrolment
- 0
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHip OsteoarthritisInterventionExclusion of opioid analgesicsPhaseNot applicableRegistry statusWithdrawn